Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease

Trial ID or NCT#

NCT07060547

Status

recruiting iconRECRUITING

Purpose

This is a study to measure liver recovery in patients with recent alcohol-associated liver injury by assessing liver function and physiology using HepQuant DuO. The HepQuant DuO Test is a blood-based test that involves a drink of a natural compound, cholate, and 2 blood samples at 20 and 60 minutes. The study team is collecting clinical and laboratory data to better monitor and treat patients who have been affected by alcohol-associated liver disease. The study has 4 visits at an outpatient clinic at 1, 3, 6, and 12 months. At each of these visits, participants will undergo a HepQuant DuO test and other standard tests. In addition, the study team will ask about a participant's alcohol use, symptoms, and quality of life.

Official Title

Investigating HepQuant DuO Test as a Biomarker in Alcohol-related Liver Disease

Eligibility Criteria

Sexes Eligible for Study: ALL
Accepts Healthy Volunteers: No

Investigator(s)

Allison Kwong
Allison Kwong
Hepatologist, Transplant hepatologist
Assistant Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Surgery (Abdominal Transplantation)
Aparna Goel
Hepatologist, Transplant hepatologist
Clinical Associate Professor, Medicine - Gastroenterology & Hepatology

Contact us to find out if this trial is right for you.

Contact

Ethan Assistant Clinical Research Coordinating Associate, BA
650-460-6119